Two projects in Inner Mongolia were supported by the national science and technology major project of "major new drug creation"

Two projects of Inner Mongolia Autonomous Region were supported by the national science and technology major project of "major new drug creation", among which "research and development of new and high-efficient anti-tumor drug rjt101 regulating tumor cell apoptosis" was funded by the state of 5.448 million yuan, and "phase clinical research of anti-tumor first-class new drug antipeptide" was funded by the state of 8.4999 million yuan It is understood that these two topics are the 2014 annual topics recommended by the science and Technology Department of Inner Mongolia Autonomous Region to the national major new drug creation and management office, which have passed the review and demonstration of major special organization departments and obtained project approval support Since the 12th Five Year Plan, Inner Mongolia Autonomous Region has carried out four national new drug creation projects The research direction involves the clinical research of Mongolian medicine namudaqi granules, the technical transformation of Compound Biejia Ruan Gan tablet, the development and clinical research of anti-tumor drugs rjt101 and antiangel peptide It is of great significance to improve the scientific and technological support level of the pharmaceutical industry, promote the transformation and application of new drug achievements, and ensure people's health through the implementation of major new drug creation projects.